Announcement & Notice - Disclosure - Investor Relations

Investor Relations

Effective Communication Drives Development

Corporate Governance Stock Information Disclosure Financials Presentations and Events Analyst Coverage Notices-Replacement of Lost Share Certificates Subscribe to Updates

Home > Investor Relations > Disclosure

Disclosure

Listing Documents Financial Report/ESG information Announcement & Notice IR Journal

2022-05-30

VOLUNTARY ANNOUNCEMENT - BUSINESS UPDATE OF COLLABORATION ON ANTIBODY-DRUG CONJUGATE
2022-05-25

VOLUNTARY ANNOUNCEMENT - COMPLETION OF FIRST DOSING OF FIRST PATIENT OF B7H4X4-1BB BISPECIFIC ANTIBODY (HBM7008) PHASE I TRIALS
2022-05-25

CHANGE OF ANNUAL GENERAL MEETING TO BE HELD ON 8 JUNE 2022 TO VIRTUAL MEETING
2022-05-11

PROPOSED ADOPTION OF THE NEW MEMORANDUM AND ARTICLES OF ASSOCIATION OF THE COMPANY
2022-05-11

PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; RE-ELECTION OF RETIRING DIRECTORS; PROPOSED AMENDMENTS TO ARTICLES OF ASSOCIATION AND NOTICE OF ANNUAL GENERAL MEETING
2022-05-11

NOTICE OF ANNUAL GENERAL MEETING
2022-05-11

FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING
2022-05-10

VOLUNTARY ANNOUNCEMENT - DATA RELEASE FORECAST OF HBM4003 AT ASCO 2022
2022-05-06

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2022
2022-05-05

LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
2022-05-05

CHANGE OF EXECUTIVE DIRECTOR
2022-04-14

APPOINTMENT OF CHIEF MEDICAL OFFICER
2022-04-07

INSIDE INFORMATION - ENTERING INTO THE OUT-LICENSE AGREEMENT WITH ASTRAZENECA FOR HBM7022
2022-04-06

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2022
2022-03-25

ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2021
2022-03-14

DATE OF BOARD MEETING
2022-03-04

RENEWAL OF CONTINUING CONNECTED TRANSACTIONS
2022-03-04

Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2022
2022-02-28

VOLUNTARY ANNOUNCEMENT - IRB APPROVAL FOR COMMENCEMENT OF PHASE I TRIAL OF B7H4X4-1BB BISPECIFIC ANTIBODY IN AUSTRALIA
2022-02-21

VOLUNTARY ANNOUNCEMENT - IND Approval for Anti-TSLP Fully Human Monoclonal Antibody in Asthma

1 ···16 17 ···21